MMP9 and myxofibrosarcoma: Recently, we reported that the antiangiogenic function of ASS1, a rate-limiting enzyme converting citrulline into arginine in the urea cycle, was also attributable to the inhibition of ASS1 on MMP-9 expression in myxofibrosarcomas [15].